EpiEP Receives $1.6M Follow-on
Summary
NEW HAVEN, CT, Connecticut Innovations (CI) announced that it has made a follow-on investment of $1 million in EpiEP, a medical device company. EpiEP is a medical device company that has developed a novel interventional platform to enable the treatment of certain deadly cardiac arrhythmias. The companys initial product, now being tested in first-in-man trials in Europe, is the EpiAccess system, which seeks to enable safe, reliable, minimally invasive access to the pericardium, or outside surface of the heart. "Connecticut is committed to improving our competitiveness and investing in companies that are bringing innovative, high-tech solutions into the market," said Governor Dannel P. Malloy. EpiEP Chief Executive Officer Pamela Bunes said, "We are delighted by the continued support and confidence we have received from Connecticut Innovations.